TuHURA Biosciences, Inc.
HURANASDAQHealthcare● Active
$2.05
+$0.08(+4.07%)
Market Cap$130230713
P/E Ratio—
52W High$3.9
52W Low$0.41
TuHURA Biosciences, Inc. (HURA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HURA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$0.13
Est. -$0.12 · -8.3%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
▼ Miss EPS
HURA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.06
Rev. $1.94B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.06
Rev. Est.$1.94B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.15 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 15, 2026 | -$0.12 | -$0.13 | -8.3% | — | — | — |
| ▼ Q1 FY2026 | Mar 31, 2026 | -$0.12 | -$0.13 | -1.4% | — | — | — |
| ▲ Q4 FY2025 | Nov 14, 2025 | -$0.15 | -$0.14 | +6.7% | — | — | — |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.14 | -$0.21 | -50.0% | — | — | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.13 | -$0.15 | -15.4% | — | — | — |
| ▼ Q1 FY2025 | Feb 26, 2025 | -$0.09 | -$8.39 | -9222.2% | — | — | — |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.10 | -$1.37 | -1270.0% | — | $0.01B | — |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.15
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026Miss
EPS Actual
-$0.13
EPS Est.
-$0.12
EPS Surpr.
-8.3%
Revenue
—
Q1 FY2026
Mar 31, 2026Miss
EPS Actual
-$0.13
EPS Est.
-$0.12
EPS Surpr.
-1.4%
Revenue
—
Q4 FY2025
Nov 14, 2025Beat
EPS Actual
-$0.14
EPS Est.
-$0.15
EPS Surpr.
+6.7%
Revenue
—
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.21
EPS Est.
-$0.14
EPS Surpr.
-50.0%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.15
EPS Est.
-$0.13
EPS Surpr.
-15.4%
Revenue
—
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
-$8.39
EPS Est.
-$0.09
EPS Surpr.
-9222.2%
Revenue
—
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$1.37
EPS Est.
-$0.10
EPS Surpr.
-1270.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.15 | $-0.15 | $-0.15 | 1 |
| Q3 FY2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q2 FY2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q1 FY2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q4 FY2026 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q3 FY2026 | $-0.14 | $-0.13 | $-0.13 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 15, 2026 | -8.3% | $2.51 | $2.31 | -7.97% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -1.4% | $1.73 | $1.79 | +3.47% |
| ▲ Q4 FY2025 | Nov 14, 2025 | +6.7% | $2.04 | $2.05 | +0.49% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -50.0% | $2.84 | $2.76 | -2.82% |
| ▼ Q2 FY2025 | May 15, 2025 | -15.4% | $3.89 | $3.84 | -1.29% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -9222.2% | $2.45 | $2.67 | +8.98% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -1270.0% | $4.94 | $4.90 | -0.81% |
| — Q2 FY2024 | Jun 30, 2024 | — | $9.45 | $10.43 | +10.37% |
Q2 FY2026-7.97%
Report Date
May 15, 2026
EPS Beat/Miss
-8.3%
Price Before
$2.51
Price After
$2.31
Q1 FY2026+3.47%
Report Date
Mar 31, 2026
EPS Beat/Miss
-1.4%
Price Before
$1.73
Price After
$1.79
Q4 FY2025+0.49%
Report Date
Nov 14, 2025
EPS Beat/Miss
+6.7%
Price Before
$2.04
Price After
$2.05
Q3 FY2025-2.82%
Report Date
Aug 14, 2025
EPS Beat/Miss
-50.0%
Price Before
$2.84
Price After
$2.76
Q2 FY2025-1.29%
Report Date
May 15, 2025
EPS Beat/Miss
-15.4%
Price Before
$3.89
Price After
$3.84
Q1 FY2025+8.98%
Report Date
Feb 26, 2025
EPS Beat/Miss
-9222.2%
Price Before
$2.45
Price After
$2.67
Q4 FY2024-0.81%
Report Date
Nov 14, 2024
EPS Beat/Miss
-1270.0%
Price Before
$4.94
Price After
$4.90
Q2 FY2024+10.37%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$9.45
Price After
$10.43
Avg Beat Reaction+0.49%
Avg Miss Reaction-0.07%
Beat Rate1 / 8 quarters
Largest Move+10.37% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HURA ends December
TuHURA Biosciences, Inc. (HURA) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.13 — missing the analyst consensus of $-0.12 by -8.3%. The next HURA earnings date is expected around September 1, 2026.
Each quarter, investors track HURA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HURA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HURA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HURA earnings · 5 questionsTuHURA Biosciences, Inc.'s next earnings report is expected around September 1, 2026. HURA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HURA historically reports after market close (AMC).
HURA earnings datewhen is HURA earningsHURA next earnings datewhen does HURA report earningsHURA earnings calendar
▸ Source: FMP · TuHURA Biosciences, Inc. SEC filings · US GAAP · TuHURA Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026